TY  - GEN
AU  - Colmenero,Jordi
AU  - Bataller,Ramón
AU  - Sancho-Bru,Pau
AU  - Domínguez,Marlene
AU  - Moreno,Montserrat
AU  - Forns,Xavier
AU  - Bruguera,Miquel
AU  - Arroyo,Vicente
AU  - Brenner,David A
AU  - Ginès,Pere
TI  - Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
SN  - 1522-1547
PY  - 2010///1026
KW  - Adaptor Proteins, Signal Transducing
KW  - Adaptor Proteins, Vesicular Transport
KW  - genetics
KW  - Administration, Oral
KW  - Angiotensin II Type 1 Receptor Blockers
KW  - administration & dosage
KW  - Biopsy, Needle
KW  - Collagen
KW  - Down-Regulation
KW  - Female
KW  - Gene Expression Regulation, Enzymologic
KW  - drug effects
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Inflammation Mediators
KW  - metabolism
KW  - Liver
KW  - Liver Cirrhosis
KW  - drug therapy
KW  - Losartan
KW  - Male
KW  - Matrix Metalloproteinase 2
KW  - Middle Aged
KW  - NADPH Oxidases
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Severity of Illness Index
KW  - Spain
KW  - Time Factors
KW  - Treatment Outcome
KW  - Urokinase-Type Plasminogen Activator
KW  - rac1 GTP-Binding Protein
N1  - Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1152/ajpgi.00162.2009
ER  -